 | • レポートコード：MRC2103G115 • 出版社/出版日：Transparency Market Research / 2020年11月27日 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界のヒドロキシクロロキン薬市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、疾患別（マラリア、関節リウマチ、COVID-19、全身性エリテマトーデス、その他）分析、流通チャネル別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場展望 ・ヒドロキシクロロキン薬の世界市場規模：疾患別（マラリア、関節リウマチ、COVID-19、全身性エリテマトーデス、その他） ・ヒドロキシクロロキン薬の世界市場規模：流通チャネル別 ・ヒドロキシクロロキン薬の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Hydroxychloroquine Drugs Market – Scope of the Report
TMR’s report on the global hydroxychloroquine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global hydroxychloroquine drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hydroxychloroquine drugs market from 2020 to 2030.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hydroxychloroquine drugs market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global hydroxychloroquine drugs market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global hydroxychloroquine drugs market. These serve as valuable tools for existing market players as well as entities interested in participating in the global hydroxychloroquine drugs market.
The report also delves into the competition landscape of the global hydroxychloroquine drugs market. Key players operating in the global hydroxychloroquine drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hydroxychloroquine drugs market that have been profiled in this report.
Key Questions Answered in Hydroxychloroquine Drugs Report
What is the sales/revenue generated by hydroxychloroquine drug providers across all regions during the forecast period?
What are the opportunities in the global hydroxychloroquine drugs market?
What are the major drivers, restraints, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which distribution channel segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Hydroxychloroquine Drugs Market – Research Objectives and Research Approach
The comprehensive report on the global hydroxychloroquine drugs market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of distribution channels.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global hydroxychloroquine drugs market in terms of disease indication, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global hydroxychloroquine drugs market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hydroxychloroquine Drugs Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Hydroxychloroquine Drugs Market Analysis and Forecast, 2018–2030
5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Regulatory Scenario by Region/globally
5.3. Disease Prevalence & Incidence Rate globally with key countries
6. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Disease Indication
6.1. Introduction & Definition
6.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
6.2.1. Malaria
6.2.2. Rheumatoid Arthritis
6.2.3. COVID-19
6.2.4. Systemic Lupus Erythematosus
6.2.5. Others
6.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication
7. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
7.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel
8. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region
9. North America Hydroxychloroquine Drugs Market Analysis and Forecast
9.1. Introduction
9.2. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
9.2.1. Malaria
9.2.2. Rheumatoid Arthritis
9.2.3. COVID-19
9.2.4. Systemic Lupus Erythematosus
9.2.5. Others
9.3. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Hydroxychloroquine Drugs Market Attractiveness Analysis
9.5.1. By Disease Indication
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Hydroxychloroquine Drugs Market Analysis and Forecast
10.1. Introduction
10.2. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
10.2.1. Malaria
10.2.2. Rheumatoid Arthritis
10.2.3. COVID-19
10.2.4. Systemic Lupus Erythematosus
10.2.5. Others
10.3. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Hydroxychloroquine Drugs Market Attractiveness Analysis
10.5.1. By Disease Indication
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Hydroxychloroquine Drugs Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
11.2.1. Malaria
11.2.2. Rheumatoid Arthritis
11.2.3. COVID-19
11.2.4. Systemic Lupus Erythematosus
11.2.5. Others
11.3. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Hydroxychloroquine Drugs Market Attractiveness Analysis
11.5.1. By Disease Indication
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Latin America Hydroxychloroquine Drugs Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
12.2.1. Malaria
12.2.2. Rheumatoid Arthritis
12.2.3. COVID-19
12.2.4. Systemic Lupus Erythematosus
12.2.5. Others
12.3. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Hydroxychloroquine Drugs Market Attractiveness Analysis
12.5.1. By Disease Indication
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Hydroxychloroquine Drugs Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
13.2.1. Malaria
13.2.2. Rheumatoid Arthritis
13.2.3. COVID-19
13.2.4. Systemic Lupus Erythematosus
13.2.5. Others
13.3. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness Analysis
13.5.1. By Disease Indication
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region
14. Competitive Landscape
14.1. Market Position Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. Sanofi
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Growth Strategies
14.2.1.3. SWOT Analysis
14.2.2. Amneal Pharmaceuticals, Inc.
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Growth Strategies
14.2.2.3. SWOT Analysis
14.2.3. Mylan N.V.
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Growth Strategies
14.2.3.3. SWOT Analysis
14.2.4. Teva Pharmaceutical Industries Ltd.
14.2.4.1. Company Overview (HQ, Business Segments)
14.2.4.2. Growth Strategies
14.2.4.3. SWOT Analysis
14.2.5. Novartis AG
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Growth Strategies
14.2.5.3. SWOT Analysis
14.2.6. Zydus Cadila
14.2.6.1. Company Overview (HQ, Business Segments)
14.2.6.2. Growth Strategies
14.2.6.3. SWOT Analysis
14.2.7. Dr. Reddy’s Laboratories Ltd.
14.2.7.1. Company Overview (HQ, Business Segments)
14.2.7.2. Growth Strategies
14.2.7.3. SWOT Analysis
14.2.8. Sun Pharmaceutical Industries Ltd.
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Growth Strategies
14.2.8.3. SWOT Analysis
14.2.9. Lupin Limited
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Growth Strategies
14.2.9.3. SWOT Analysis
14.2.10. Prasco Laboratories
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Company Financials
14.2.10.3. Growth Strategies
14.2.10.4. SWOT Analysis
Table 01: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 02: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 03: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 04: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country, 2018–2030
Table 05: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 06: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 07: Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 08: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 09: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 10: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 11: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 12: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 13: Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 15: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Middle East & Africa Remote Patient Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030
Table 18: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030